Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH)
- Supplementary File 1:
PDF-Document (PDF, 363 KiB)
Lee, J.H.; Oh, J.Y.; Kim, S.H.; Oh, I.J.; Lee, Y.-h.; Lee, K.W.; Lee, W.H.; Kim, J.-H. Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH). Biomolecules 2020, 10, 1426. https://doi.org/10.3390/biom10101426
Lee JH, Oh JY, Kim SH, Oh IJ, Lee Y-h, Lee KW, Lee WH, Kim J-H. Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH). Biomolecules. 2020; 10(10):1426. https://doi.org/10.3390/biom10101426
Chicago/Turabian StyleLee, Jin H., Ji Y. Oh, Soo H. Kim, In J. Oh, Yong-ho Lee, Keun W. Lee, Woong H. Lee, and Jeong-Hwan Kim. 2020. "Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH)" Biomolecules 10, no. 10: 1426. https://doi.org/10.3390/biom10101426